Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas

Despite recent advances in the field, treatment options for metastatic soft tissue sarcoma patients are limited. Eribulin, an antimitotic derived from the natural marine sponge product halichondrin B, is currently approved for the treatment of metastatic breast cancer. Following the promising activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Noujaim, Jonathan, Alam, Salma, Thway, Khin, Jones, Robin Lewis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027783/
https://www.ncbi.nlm.nih.gov/pubmed/27688604
http://dx.doi.org/10.4103/0971-5851.190359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027783/
https://www.ncbi.nlm.nih.gov/pubmed/27688604
http://dx.doi.org/10.4103/0971-5851.190359

Ejemplares similares